Page 6 - Bart Bandy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bart bandy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bart Bandy Today - Breaking & Trending Today

4 High-Volume Penny Stocks For Your March Watch List | FinancialContent Business Page


Novan Inc. (NASDAQ: NOVN) Obalon Therapeutics Inc.
One of the biggest gainers during the second week of March is Obalon Therapeutics. On Tuesday, shares of OBLN skyrocketed. While no news came out on Tuesday to spark this gain, we saw several similar biotech penny stocks jump during the day. Obalon is a producer of medical devices that help treat obesity in the U.S. While it does have operations worldwide, its primary market is in America. Only a month or so ago, the company announced a merger with the weight loss solutions company, ReShape Lifesciences Inc. Upon the announcement, shares of OBLN skyrocketed by over 500%.  ....

United States , Richie Cunningham , Penny Stocks To Watch Novan Inc , Obalon Therapeutics Inc , Penny Stocks To Watch Obalon Therapeutics Inc , Tyme Technologies Inc , Novan Inc , Atossa Therapeutics Inc , Life Sciences Inc , Penny Stocks To Watch Tyme Technologies Inc , Penny Stocks To Watch Atossa Therapeutics Inc , Penny Stocks , Watch As Markets Try To Recover , Penny Stocks To Watch , Reshape Lifesciences , Bart Bandy , Balloon System , Penny Stocks To Buy With , Watch This , Watch Obalon Therapeutics Inc , Watch Atossa Therapeutics Inc , Watch Tyme Technologies Inc , Watch Novan , ஒன்றுபட்டது மாநிலங்களில் , பணக்காரர் கன்னிங்ஹாம் , டைம் தொழில்நுட்பங்கள் இன்க் ,

ReShape Lifesciences Inc.: ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results


ReShape Lifesciences Inc.: ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results
Recent Highlights and Accomplishments
Entered into a definitive merger agreement with Obalon Therapeutics, Inc., a company focused on developing and commercializing novel technologies for weight loss.
Strategic merger provides market synergies and the opportunity for the combined company to trade on NASDAQ.
Initiated enrollment of healthcare professionals in ReShapeCare
, the Company s first-in-class reimbursed, telehealth-based coaching program providing patients a tailored, high-touch, and personalized virtual treatment.
Received funding from a National Institutes of Health (NIH) Small Business Innovation Research grant to identify and successfully meet the necessary endpoints of a pre-clinical study with ReShape s Dual Block Stimulation Neuromodulation (DBSN) technology currently in development for the treatment of type 2 diabetes. ....

James Salierno , Thomas Stankovich , Truth Group , Small Business Innovation Research , Obalon Therapeutics Inc , Company Contact , National Institutes Of Health , Exchange Commission , Life Sciences Inc , Reshape Lifesciences , Obalon Therapeutics , National Institutes , Dual Block Stimulation Neuromodulation , Bart Bandy , Chief Executive Officer , Reshape Vest , Lap Band System , Investor Relations , Shape Lifesciences , Reshape Vest System , Reshapecare Virtual , Looking Safe Harbor Statement , Private Securities Litigation Reform Act , Nasdaq Capital Market , Ended December , Life Sciences ,